Search PubMed⌕ Search

Biomedical subjects

G Miotto

Publications and source records attributed to G Miotto.

21 records · Page 2Linked to original sources
PubMed1988

On the mechanism of spermine transport in liver mitochondria.

Spermine penetrates the mitochondrial matrix at significant rates which increase sharply and non-ohmically with membrane potential. In this respect, spermine uptake is qualitatively similar to that of other cations whose electrophoretic transport has been studied in mitochondria. At 200 mV and 1 mM spermine, the observed rate of spermine uptake was about 7 nmol x mg-1 x min-1, and the rate constant was about 8 times greater than that of tetraethylammonium cation. These rates are remarkably rapid considering that spermine is largely tetravalent at the pH of the experiment. The fluxes of spermine and tetraethylammonium are log-linear with membrane potential. The slope of the tetraethylammonium plot is consistent with leakage of this ion across a sharp Eyring barrier located in the middle of the membrane. The slope of the spermine plot is half that predicted by such a leak pathway, raising the possibility that spermine may cross the inner membrane by means of a channel. Whatever its mechanism of penetration, if comparable rates of uptake obtain in vivo and if spermine is not metabolized within the mitochondrial matrix, then a separate efflux mechanism would appear to be required to prevent unlimited spermine loading.

Animals↗
PubMed1987

Transport and function of L-carnitine and L-propionylcarnitine: relevance to some cardiomyopathies and cardiac ischemia.

Carnitine, an essential cofactor in fatty acid oxidation, plays a central role in myocardial metabolism. Interpretation of the biochemical features of disturbed myocardial function, particularly in ischemia, may be facilitated by understanding carnitine biosynthesis, transport and function. Biosynthesis: In man, deoxycarnitine, the immediate precursor of carnitine, is synthesized in all tissues, whereas the last step, the conversion of deoxycarnitine into carnitine may only take place in liver, kidney and brain (Figs. 1 and 2). Deoxycarnitine formed by organs like muscle or heart is released into the plasma, taken up by liver and kidney, converted into carnitine which is secreted into the bloodstream to be taken up by heart or muscle (Fig. 2). Carnitine transport and cellular function: The myocardial uptake of carnitine against a large concentration gradient (Table 1) occurs in an 1:1 exchange-diffusion process. Under physiological conditions, intracellular deoxycarnitine is exported and extracellular carnitine is imported. According to this model, myocardial carnitine deficiency may be due either to a functional alteration of the sarcolemmal carnitine carrier or to a deficient synthesis of deoxycarnitine. D-carnitine, acetylcarnitine and long-chain acylcarnitine esters are also transported by the carrier at different rates. This might account for the release of endogenous acylcarnitines accumulated in anoxic or ischemic conditions, contributing to the cardioprotective effect of carnitine by reduction in intracellular long-chain acyl-coenzyme A.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗